Navigation Links
Glysure Presents Successful Clinical Trial Results at ISICEM
Date:3/20/2012

OXFORD, England, March 20, 2012 /PRNewswire/ --

GlySure Limited, developer of in-hospital continuous blood glucose monitoring systems, announced that Dr Krishna Prasad is presenting the results of its Intensive Care Unit (ICU) Pilot Trial for the first time at the 32nd International Symposium on Intensive Care and Emergency Medicine (ISICEM) being held in Brussels, Belgium from March 20th - 23rd, 2012.

The data show that the optical fluorescence sensor can successfully measure blood glucose levels with a high degree of accuracy across a wide range of intensive care patients throughout their length of stay in the ICU.

The pioneering new research results being presented at ISICEM were collected from critically ill patients during GlySure's recent pilot ICU clinical trial. It is the first major clinical milestone for the venture capital backed medical technology company.  GlySure believes its continuous intravascular glucose monitoring system has the potential to improve outcomes for over 8 million ICU patients annually.

At ISICEM Principal Investigator Dr Krishna Prasad will present the data from eighteen ICU patients with a broad range of conditions and co-morbidities including cardiac surgery, cerebral trauma, sepsis, diabetes and hypertension.  All of the critically ill patients were monitored continuously and accurately for blood glucose levels throughout their length of stay in the ICU - up to 100 hours of continuous monitoring.

"Clinicians have been waiting for a continuous real-time blood glucose monitor to support implementation of Tight Glycemic Control protocols for much of the past decade," said Dr Prasad.  

GlySure CEO Chris Jones said: "We are very excited by the results of the pilot ICU clinical trial and are delighted to be able to share them for the first time at ISICEM. We are looking forward to beginning our European and US clinical regulatory trials and bringing this t
'/>"/>

SOURCE GlySure Limited
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. GlySure Secures $10.9 Million in Series C Financing Round
2. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
3. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
4. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
5. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
6. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
7. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
8. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
9. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
10. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
11. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 Today, ... Inc. (NASDAQ: GILD ), Health Management Associates Inc. ... IDXX ), ISIS Pharmaceuticals Inc. (NASDAQ: ISIS ... access these reports free of charge - including full price ... below. Gilead Sciences, Inc. Research Report ...
(Date:6/18/2013)... 18, 2013 Apama Medical, a privately ... of next-generation atrial fibrillation technologies, today announced the ... US Patent and Trademark Office (USPTO), titled "Low ... assemblies for use on expandable structures such as ... procedures. "We are grateful to the ...
(Date:6/17/2013)... 17, 2013 Velplex, LLC announced this week ... platform that connects buyers and sellers of discount ... leader. Why? It,s because the business ... familiar with the dental industry. They have 50 years ... diligently worked to negotiate some of the best prices ...
Breaking Medicine Technology:Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6TopProdeals.com Rises to Top as Discount Dental Supply Leader 2
... SHENZHEN, China , April 30 ... or the "Company"), a leading manufacturer of,medical dressings, medical disposables and ... that it,closed its previously announced public offering of 1,380,000 shares of ... ...
... VIEW, Calif. , April 30 IRIDEX Corporation, (Nasdaq: ... 532 laser systems. The IQ 532 is a high-power, 532 nm, dual ... diseases such as diabetic retinopathy, age-related macular degeneration and glaucoma; and for ... , , ...
Cached Medicine Technology:Winner Medical Group Inc. Announces Closing of $8.4 Million Public Offering of Common Stock 2Winner Medical Group Inc. Announces Closing of $8.4 Million Public Offering of Common Stock 3Winner Medical Group Inc. Announces Closing of $8.4 Million Public Offering of Common Stock 4IRIDEX Announces First Commercial Shipment of New IQ 532(TM) Laser Systems 2
(Date:6/19/2013)... 19, 2013 To survive when your plane goes ... veteran Captain W.S. “Bud” Orr, the most important item in a ... Sharon Kleyne on the Sharon Kleyne Hour Power of Water radio ... he always placed extra water ahead of guns or even food. ... survival kits that pilots could carry on planes in Vietnam. He ...
(Date:6/19/2013)... 2013 In honor of women everywhere, ... providing information that women can use to improve their ... women should pay close attention to their health, as ... changes a woman’s body undergoes while pregnant can increase ... says Dr. Ray Workman, a leading vein doctor at ...
(Date:6/19/2013)... 2013 According to Vanessa Grigoriadis, a ... “psychonauts” are creating new designer drugs featuring psychoactive effects ... published documents and patented formulas. She reported her findings ... on June 4. , “Some of these drugs ... tested on humans. Maybe some of them are tested ...
(Date:6/19/2013)... As more and more people realize the ... energy-saving products to replace those unhealthy traditional lamps. Zhontian ... a variety of products to meet customers' needs. Apart ... and LED spot lights , the new product ... to customers by Zhongtian Lighting recently. This model uses ...
(Date:6/19/2013)... 2013 Indosoft Inc., developers of ... for Asterisk, announced today the availability of its ... offers improved options for extracting, consolidating and presenting ... contact center management. , Large Asterisk based contact ... it happens from the call center software. This ...
Breaking Medicine News(10 mins):Health News:Vietnam Navy Pilot Reveals to Radio Host Sharon Kleyne That He Carried Extra Water Not a Gun in Survival Kit 2Health News:Novant Health Vein Specialists Promotes Women’s Health with Social Media Campaign 2Health News:Dangerous Designer Drugs Dodge Legal System 2Health News:Dangerous Designer Drugs Dodge Legal System 3Health News:3W High Power LED Down Light [ZT-D70-311F] Is Introduced to Customers by Zhongtian Lighting 2Health News:Indosoft Improves Q-Suite Real-time ACD Reporting to Enhance Contact Center Productivity 2
... , Feb. 1 Givers can double their ... The National Christian Foundation (NCF) at www.nationalchristian.com/haitirenewal . Thanks ... Haiti Renewal Fund will be matched dollar-for-dollar up to ... for rebuilding and renewing the country. For more information and ...
... , SANTA ANA, Calif. , Feb. ... announced that it has received and accepted subscriptions aggregating 2,000,000 shares ... the minimum offering amount required by the state of Ohio ... , About Grubb & Ellis Healthcare REIT II , ...
... the contrast agent gadolinium during magnetic resonance imaging (MRI) ... node metastases, according to a new study published online ... Cancer Institute . Gadolinium-enhanced MRI is primarily used to ... detect and evaluate lymph node metastases. In light of ...
... One of the holy grails of local anesthesia is the ... sensation while not affecting motor function. Now, researchers at Children,s ... do just that. If it proves to work in humans ... useful in a variety of medical applications, providing, for example, ...
... may someday improve prevention efforts , MONDAY, Feb. 1 (HealthDay ... a pregnant mouse leads to changes inside the uterus that ... fetus. , The findings, published online in the ... to prevent and treat premature birth, the study,s senior investigator, ...
... Featuring ... convert into a stylish, comfortable footrest , ... Las Vegas (PRWEB) February 1, 2010 -- Human Touch ... and other wellness solutions, announced today the introduction of its new and most advanced ...
Cached Medicine News:Health News:The National Christian Foundation Offers to Match Gifts to Haiti 2Health News:Grubb & Ellis Healthcare REIT II Meets Ohio's Minimum Offering 2Health News:News brief: Contrast agent with MRI improves detection of lymph nodes metastases 2Health News:Anesthetic approach stops pain without affecting motor function 2Health News:Human Touch Introduces New CirQlation™ Elite Foot & Calf Massager Providing Ultimate Targeted Relief for Tired Feet and Calves 2Health News:Human Touch Introduces New CirQlation™ Elite Foot & Calf Massager Providing Ultimate Targeted Relief for Tired Feet and Calves 3Health News:Human Touch Introduces New CirQlation™ Elite Foot & Calf Massager Providing Ultimate Targeted Relief for Tired Feet and Calves 4
... kit is an enzyme immunometric assay ... a liquid phase,incubation, designed for the ... The microplate is coated,with anti-rabbit antibodies.,Calibrators ... anti-rabbit antibody-coated wells, along with rabbit ...
Myoglobin RIA Lipid / Protein Quantification, Cardiovascular 024-IDC-11 Muscle Disease...
ACTH EIA Hypertension / Cardiac Evaluation, Cardiovascular 021-SDX018...
Anti-Gliadin IgG (Ab) EIA Gastrointestinal Markers 027-GD16 Celiac Disease Food Allergy...
Medicine Products: